Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches
Status: | Terminated |
---|---|
Conditions: | Migraine Headaches |
Therapuetic Areas: | Neurology |
Healthy: | No |
Age Range: | 18 - 64 |
Updated: | 12/7/2017 |
Start Date: | July 2011 |
End Date: | July 2012 |
Droperidol Versus Metoclopramide + Diphenhydramine for the Treatment of Primary Headaches in the Emergency Department: A Prospective Randomized, Double-blinded Trial.
The purpose of this study is to determine if droperidol is equally as effective as
metoclopramide for treatment of primary headaches in the Emergency Department.
metoclopramide for treatment of primary headaches in the Emergency Department.
Inclusion Criteria:
- 18 years old to 65 years old, diagnosis of primary headache
Exclusion Criteria:
- Allergy to study medications, pregnant, breast-feeding, prisoners, non-english
speaking, not eligible to receive droperidol based on ED protocol (see below),
patients in whom head trauma, infection, vascular disorders, and disorders of facial
or cranial structures are suspected
ED Droperidol Protocol
Droperidol must NOT be used in patients with any of the following:
- Known or suspected QT prolongation, including congenital long QT syndrome
- Cardiac Disease [cardiomyopathy, congestive heart failure, hypertension, ischemic
heart disease, myocardial infarction, bradycardia (< 50 bpm)]
- History of the following:
- Renal failure
- Cerebrovascular disease
- Diabetes or hypoglycemia
- Alcoholism/alcohol abuse
- Pituitary insufficiency
- Hypothyroidism
- Hypothermia
- Anorexia
- Advanced age (>65 yrs)
- Use of the following medications: digoxin, benzodiazepine, diuretics, IV opiates, or
other medications known to prolong the QTc interval.
We found this trial at
1
site
University of Iowa Hospitals and Clinics University of Iowa Hospitals and Clinics—recognized as one of...
Click here to add this to my saved trials